Living

US health department proposes testosterone therapy label updates

By Reuters Reuters
A man casts a shadow as he walks toward the Hubert H. Humphrey Building, headquarters of the Department of Health and Human Services (HHS) in Washington, D.C., U.S., April 1, 2025. REUTERS/Kevin Lamarque
A man casts a shadow as he walks toward the Hubert H. Humphrey Building, headquarters of the Department of Health and Human Services (HHS) in Washington, D.C., U.S., April 1, 2025. REUTERS/Kevin Lamarque Kevin Lamarque Reuters

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data and other evidence.

The proposed changes would remove limits on use in men with age-related low testosterone, revise warnings on enlarged prostate and update information related to prostate cancer risk, the U.S. Department of Health and Human Services said.

(Reporting by Kunal Das in Bengaluru; Editing by Anil D'Silva)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published June 18, 2026 at 2:45 PM.

Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER